Showing results (61-70 of 86) with videos related to
Sort By:
Pageof 9
European Journal of Dermatology : EJD|December 31, 2014
[¹²³I]ICF01012 melanoma imaging and [¹³¹I]ICF01012 dosimetry allow adapted internal targeted radiotherapy in preclinical melanoma modelsClaire Viallard, Yann Perrot, Zied Boudhraa, et al.Scientific Reports|November 4, 2017
Antibody PEGylation in bioorthogonal pretargeting with trans-cyclooctene/tetrazine cycloaddition: in vitro and in vivo evaluation in colorectal cancer modelsAurélie Rondon, Nancy Ty, Jean-Baptiste Bequignat, et al.Nuclear Medicine and Biology|October 14, 2008
Melanoma affinity in mice and immunosuppressed sheep of [(125)I]N-(4-dipropylaminobutyl)-4-iodobenzamide, a new targeting agentPierre Labarre, Janine Papon, Alison H Rose, et al.EJNMMI Research|September 26, 2025
Tumor sink effect on melanin-ligand [131I]ICF01012 in melanoma and its implications for targeted radionuclide therapyElodie Jouberton, Sophie Besse, Tommy Billoux, et al.Chemical Communications (Cambridge, England)|March 8, 2013
In vivo evidence of the targeting of cartilaginous tissue by pyridinium functionalized nanoparticlesJessica Morlieras, Jean-Michel Chezal, Elizabeth Miot-Noirault, et al.European Journal of Medicinal Chemistry|April 17, 2012
Imidazonaphthyridine systems (part 2): Functionalization of the phenyl ring linked to the pyridine pharmacophore and its replacement by a pyridinone ring produces intriguing differences in cytocidal activityNicolas Masurier, Eric Debiton, Alicia Jacquemet, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 12, 2024
Branched pegylated linker-auristatin to control hydrophobicity for the production of homogeneous minibody-drug conjugate against HER2-positive breast cancerEmmanuel Douez, Emilie Allard-Vannier, Imène Ait Mohamed Amar, et al.Bioorganic & Medicinal Chemistry|July 29, 2008
Design, synthesis and preliminary biological evaluation of acridine compounds as potential agents for a combined targeted chemo-radionuclide therapy approach to melanomaNicolas Desbois, Maryline Gardette, Janine Papon, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|June 28, 2014
Small rigid platforms functionalization with quaternary ammonium: targeting extracellular matrix of chondrosarcomaElisabeth Miot-Noirault, Aurélien Vidal, Jessica Morlieras, et al.Journal of Medicinal Chemistry|February 13, 2023
Homologation of the Alkyl Side Chain of Antimitotic Phenyl 4-(2-Oxo-3-alkylimidazolidin-1-yl)benzenesulfonate Prodrugs Selectively Targeting CYP1A1-Expressing Breast Cancers Improves Their Stability in Rodent Liver MicrosomesAtziri Corin Chavez Alvarez, Chahrazed Bouzriba, Emmanuel Moreau, et al.Pageof 9